A Phase I/II Trial of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB)
A Phase I/II Trial of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB)
Recruiting · NCT07640984 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Trial of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB) | Mucopolysaccharidosis IIIB | Recruiting | Phase 1 / Phase 2 | 2026-09-21 | NCT07640984 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| JCR Pharmaceuticals Co., Ltd. | 8 |
| MEDIPAL HOLDINGS CORPORATION | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Hospital Oakland Research Institution, Attn: 2900 Wing | Oakland | United States | 1 |
| Great Ormond Street Hospital for Children | London | United Kingdom | 24 |
| Lysosomal and Rare Disorders Research and Treatment Center (LDRTC) | Fairfax | United States | 2 |
| University Medical Center Hamburg-Eppendorf | Hamburg | Germany | 26 |
| UPMC Children's Hospital of Pittsburgh | Pittsburgh | United States | 70 |